As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Pantai Hospital Kuala Lumpur Powers Malaysia’s Biggest Marathon with Heart
Every effort counts with a record-breaking 42,000 participants registering for the 17th edition of Malaysia’s premier distance running event.
Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care
Step inside a new era of connected, technology-enabled care designed around patients’ needs.
IHH Healthcare Shines at The Economic Times Healthcare Awards 2025
Explore the award-winning care and innovation across our network.
Gleneagles Hospital Chennai Propels the Frontier of Advanced Cancer Care and Robotic Oncology
On 27 September, over 300 delegates converge to exchange knowledge and deliberate on advanced cancer surgery, robotic oncology, head and neck oncology, radiation therapy, and supportive care.
Gleneagles JPMC Partners Ministry of Health Brunei in Nation-wide Fight Against Non-communicable Diseases
Gleneagles JPMC is reinforcing its commitment to world-class cardiac care as part of Brunei’s whole-of-nation effort to combat non-communicable diseases.
